Figures & data
Table I. Average aggregation size and zeta potential in a solution of TiO2–NPs.
Figure 2. The result of western blotting, showing the effect of TiO2-NPs on α-Syn expression in PC12 cells.
![Figure 2. The result of western blotting, showing the effect of TiO2-NPs on α-Syn expression in PC12 cells.](/cms/asset/19850ed4-b046-4c97-b0ca-f425e6ad88c9/ianb_a_980507_f0002_b.gif)
Figure 3. The result of western blotting, showing the α-Syn expression in PC12 cells after treatment with TiO2-NPs and NAC.
![Figure 3. The result of western blotting, showing the α-Syn expression in PC12 cells after treatment with TiO2-NPs and NAC.](/cms/asset/d38fe6e0-8252-4894-b222-ed62c81e2c1c/ianb_a_980507_f0003_b.gif)
Table II. The result of western blotting, showing the effect of TiO2-NPs on α-Syn in PC12 cells (grey value, %).
Figure 4. The result of immunofluorescent staining, showing the effect of TiO2-NPs on α-Syn aggregation in PC12 cells.
![Figure 4. The result of immunofluorescent staining, showing the effect of TiO2-NPs on α-Syn aggregation in PC12 cells.](/cms/asset/548b4547-df22-4048-9d44-7cf87a16eff8/ianb_a_980507_f0004_oc.jpg)
Figure 5. The result of western blotting, showing the expression of parkin and UCH-L1 after treatment with TiO2-NPs.
![Figure 5. The result of western blotting, showing the expression of parkin and UCH-L1 after treatment with TiO2-NPs.](/cms/asset/e861c32a-15f6-43fd-aa2a-eeb1726f771b/ianb_a_980507_f0005_b.gif)
Table III. Parkin and UCH-L1 expression levels after TiO2-NPs treatment in PC12 cells (grey value, %).